𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical expression of glutathione S-transferase πι can predict chemotherapy response in patients with nonsmall cell lung carcinoma


Book ID
123010364
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
137 KB
Volume
16
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Immunohistochemical expression of glutat
✍ Fen Bai; Yoichi Nakanishi; Masayuki Kawasaki; Koichi Takayama; Jun Yatsunami; Xi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

## BACKGROUND. Resistance to chemotherapy agents is a major problem in the treatment of patients with nonsmall cell lung carcinoma (NSCLC). Recent studies have indicated that glutathione S-transferase-n (GST-n) may play an important role in the resistance of cancer cells to alkylating agents, inclu

Association between glutathione S-transf
✍ Charles Lu; Margaret R. Spitz; Hua Zhao; Qiong Dong; Mylene Truong; Joe Y. Chang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

## Abstract ## BACKGROUND Glutathione S‐transferase (GST) π (GSTP1) is a detoxification enzyme with substrate specificity for both exogenous carcinogens and chemotherapy agents. Genetic polymorphisms of __GSTP1__ exon 5 (Ile105Val) and exon 6 (Ala114Val) appear to reduce this enzyme's activity. Pr

Inverse expression of dihydrodiol dehydr
✍ Liang-Shun Wang; Kuan-Chih Chow; Yu-Chung Wu; Tze-Yi Lin; Wing-Yin Li 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 193 KB

## Abstract We investigated the significances of the expressions of dihydrodiol dehydrogenase (DDH) and glutathione‐S‐transferase (GST) in patients with esophageal squamous cell carcinoma (ESCC). By using immunohistochemistry, we measured expressions of DDH, GST, COX‐2, nm23‐H1, HER‐2/neu and mdr‐1

Single agent versus combination chemothe
✍ Rogerio C. Lilenbaum; Patricia Langenberg; Kay Dickersin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in